Gastroenterology

MD IQ

News from the FDA/CDC

FDA OKs new treatment for erosive esophagitis

Vonoprazan provides clinicians with a “new first-in-class therapeutic option that demonstrated faster healing in the more difficult-to-treat GERD...

Pages